function decreases during treatment, PegIntron therapy should be discontinued. Combination therapy : Patients with creatinine clearance < 50 ml/minute must not be treated with PegIntron in combination with ribavirin (see ribavirin SPC). When administered in combination with ribavirin , subjects with...
the PegIntron dose should be reduced by 25%. Patients with severe renal dysfunction (creatinine clearance 10-29 mL/min), including those on hemodialysis, should have the PegIntron dose reduced by 50%. If renal function decreases during treatment, PegIntron therapy should be discontinued. When Pe...
☞ If serious adverse reaction occurs, know that drug will be discontinued or dosages adjusted accordingly. • Monitor patient for development of diabetes mellitus, hypothyroidism, or hyperthyroidism. • Be aware that if HCV level remains high after 6 months, drug should be discontinued. Patien...
Two HCV Drugs to Be DiscontinuedElizabeth GoughGordon
If renal function decreases during treatment, PegIntron therapy should be discontinued. When PegIntron is administered in combination with REBETOL, subjects with impaired renal function or those over the age of 50 should be more carefully monitored with respect to the development of anemia. PegIntron...
If renal function decreases during treatment, PegIntron therapy should be discontinued. When PegIntron is administered in combination with REBETOL, subjects with impaired renal function or those over the age of 50 should be more carefully monitored with respect to the development of anemia. PegIntron...
If renal function decreases during treatment, PegIntron therapy should be discontinued. When PegIntron is administered in combination with REBETOL, subjects with impaired renal function or those over the age of 50 should be more carefully monitored with respect to the development of anemia. PegIntron...